Zhang YY, Hu B. Endoscopic polidocanol foam sclerobanding for the treatment of Grade II-III internal hemorrhoids: The focus of clinical practice. World J Gastroenterol 2024; 30(38): 4246-4248 [PMID: 39493328 DOI: 10.3748/wjg.v30.i38.4246]
Corresponding Author of This Article
Bing Hu, MD, Professor, Department of Gastroenterology and Hepatology, Digestive Endoscopy Medical Engineering Research Laboratory, West China Hospital, Med-X Center for Materials, West China Hospital, Sichuan University, No. 37 Guo Xue Alley, Wuhou District, Chengdu 610041, Sichuan Province, China. hubingnj@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Oct 14, 2024; 30(38): 4246-4248 Published online Oct 14, 2024. doi: 10.3748/wjg.v30.i38.4246
Endoscopic polidocanol foam sclerobanding for the treatment of Grade II-III internal hemorrhoids: The focus of clinical practice
Yu-Yan Zhang, Bing Hu
Yu-Yan Zhang, Bing Hu, Department of Gastroenterology and Hepatology, Digestive Endoscopy Medical Engineering Research Laboratory, West China Hospital, Med-X Center for Materials, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
Author contributions: Zhang YY and Hu B coauthored and revised the manuscript; All the authors have read and approved the final manuscript.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Bing Hu, MD, Professor, Department of Gastroenterology and Hepatology, Digestive Endoscopy Medical Engineering Research Laboratory, West China Hospital, Med-X Center for Materials, West China Hospital, Sichuan University, No. 37 Guo Xue Alley, Wuhou District, Chengdu 610041, Sichuan Province, China. hubingnj@163.com
Received: July 23, 2024 Revised: September 13, 2024 Accepted: September 18, 2024 Published online: October 14, 2024 Processing time: 68 Days and 0.5 Hours
Abstract
We have read the article by Qu et al with great interest, as it presents an integration of endoscopic polidocanol foam sclerotherapy with rubber band ligation in patients with Grade II-III internal hemorrhoids. The authors conducted a prospective, multicenter, randomized study to evaluate the long-term symptomatic and endoscopic efficacy of this combined intervention. In this discussion, we focus on the procedural steps of this combined strategy and suggest potential avenues for future research.
Core Tip: Hemorrhoid disease is common, and multiple intervention methods exist. Qu et al conducted a prospective, multicenter, randomized study to demonstrate the effectiveness and safety of combining endoscopic sclerotherapy and rubber band ligation in managing Grade II-III internal hemorrhoids. We aim to share our concerns about the specific procedures of this combined strategy and to highlight some potential directions for subsequent research.
